These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8360583)

  • 1. Chimeric antibodies.
    Billetta R; Lobuglio AF
    Int Rev Immunol; 1993; 10(2-3):165-76. PubMed ID: 8360583
    [No Abstract]   [Full Text] [Related]  

  • 2. The future of monoclonal antibody engineering.
    Renner C; Hartmann F; Pfreundschuh M
    Ann Hematol; 2001; 80 Suppl 3():B127-9. PubMed ID: 11757694
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant chimeric monoclonal antibodies.
    Morrison SL; Schlom J
    Important Adv Oncol; 1990; ():3-18. PubMed ID: 2182522
    [No Abstract]   [Full Text] [Related]  

  • 4. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract]   [Full Text] [Related]  

  • 5. The construction of a mouse/human chimeric antibody against human breast cancer cells.
    Meulemans E; Vandevyver C; Volckaert G; Raus J
    Year Immunol; 1993; 7():131-6. PubMed ID: 8372502
    [No Abstract]   [Full Text] [Related]  

  • 6. Engineering of antibodies for breast cancer therapy: construction of chimeric and humanized versions of the murine monoclonal antibody BrE-3.
    Couto JR; Blank EW; Peterson JA; Kiwan R; Padlan EA; Ceriani RL
    Adv Exp Med Biol; 1994; 353():55-9. PubMed ID: 7985542
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic antibodies: magic bullets hit the target.
    Gura T
    Nature; 2002 Jun; 417(6889):584-6. PubMed ID: 12050630
    [No Abstract]   [Full Text] [Related]  

  • 8. Mouse/human chimeric IgE antibodies directed to the house dust mite allergen Der p 2.
    Schuurman J; Lourens TE; Perdok GJ; Parren PW; Aalberse RC
    Int Arch Allergy Immunol; 1995; 107(1-3):465-6. PubMed ID: 7613217
    [No Abstract]   [Full Text] [Related]  

  • 9. Construction of chicken-mouse chimeric antibody and immunogenicity in mice.
    Tateishi Y; Nishimichi N; Horiuchi H; Furusawa S; Matsuda H
    J Vet Med Sci; 2008 Apr; 70(4):397-400. PubMed ID: 18460836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning, sequencing and expression of immunoglobulin variable regions of murine monoclonal antibodies specific for the P1.7 and P1.16 PorA protein loops of Neisseria meningitidis.
    Ihle Ø; Beckstrøm KJ; Michaelsen TE
    Scand J Immunol; 2003 May; 57(5):453-62. PubMed ID: 12753502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural correspondences between mouse and human immunoglobulin VH genes. Application to the humanization of mouse monoclonal antibodies.
    Poul MA; Lefranc MP
    Ann N Y Acad Sci; 1995 Sep; 764():359-61. PubMed ID: 7486546
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic antibodies and antibody fusion proteins.
    Rohrbach P; Broders O; Toleikis L; Dübel S
    Biotechnol Genet Eng Rev; 2003; 20():137-63. PubMed ID: 14997850
    [No Abstract]   [Full Text] [Related]  

  • 13. Self-assembly of antibodies by chemical induction.
    Li Q; Hapka D; Chen H; Vallera DA; Wagner CR
    Angew Chem Int Ed Engl; 2008; 47(52):10179-82. PubMed ID: 19025747
    [No Abstract]   [Full Text] [Related]  

  • 14. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.
    Couto JR; Blank EW; Peterson JA; Ceriani RL
    Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and expression of a chimeric antibody directed against the human transferrin receptor.
    Hoogenboom HR; Raus JC; Volckaert G
    J Immunol; 1990 Apr; 144(8):3211-7. PubMed ID: 2324499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of engineered antibodies.
    Hwang WY; Foote J
    Methods; 2005 May; 36(1):3-10. PubMed ID: 15848070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of humanized monoclonal antibodies by 'best fit' framework selection and recombinant polymerase chain reaction.
    Lewis AP; Crowe JS
    Year Immunol; 1993; 7():110-8. PubMed ID: 8372500
    [No Abstract]   [Full Text] [Related]  

  • 18. Epitope analysis and primary structures of variable regions of anti-human FcepsilonRI monoclonal antibodies, and expression of the chimeric antibodies fused with human constant regions.
    Takai T; Yuuki T; Iwamoto-Yasue N; Okumura K; Ra C
    Biosci Biotechnol Biochem; 2000 Sep; 64(9):1856-67. PubMed ID: 11055388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
    Pardridge WM; Boado RJ
    Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.